randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology A multicenter, randomized, placebo-controlled, double-blind

A multicenter, randomized, placebo controlled, double blind phase 3 trial with open arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome Kidney International In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell Acetyl L Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta Analysis of Randomized Controlled Trials PLOS One Acetyl l carnitine versus placebo for migraine prophylaxis: A randomized, triple blind, crossover study Knut Hagen, Eiliv Brenner, Mattias Linde, Gril Bruvik Gravdahl, Erling Andreas Tronvik, Morten Engstrm, Ursula Sonnewald, Grethe Helde, Lars Jacob Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double blinded placebo controlled trial ScienceDirect Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet

SKU: 48066282260 · From southroadsurgery.com.au